Ligand · TFY
TFY · (1R,2S,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methyl-6-oxidanyl-heptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-2-[2-(1,2,3,4-tetrazol-1-yl)ethyl]cyclohexane-1,3-diol
TFY, (1R,2S,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methyl-6-oxidanyl-heptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-2-[2-(1,2,3,4-tetrazol-1-yl)ethyl]cyclohexane-1,3-diol (C30 H48 N4 O3, 512.7…
- Component
- TFY
- Formula
- C30 H48 N4 O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
TFY in 2 structures; the first of them:
- 4ITF · Crystal structure of the human vitamin D receptor ligand binding domain complexed with… · TFY A501 · binds THR142, TYR143, ASP144, TYR147, PHE150, LEU227, LEU230, LEU233 and 23 more
- 4ITF · Crystal structure of the human vitamin D receptor ligand binding domain complexed with… · TFY A501 · binds THR142, TYR143, ASP144, TYR147, PHE150, LEU227, LEU230, LEU233 and 23 more
Residues it binds most
LEU 2, TYR 2, SER 2, VAL 2, HIS 2, ILE 2, PHE 2, ARG 2, ASP 2, CYS 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.